Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center

Dalbavancin is a lipoglycopeptide approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The aim of the study was to evaluate the efficacy and safety in all patients who received at least one administration of dalbavancin. Methods: We carried out a retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Brescini, Lucia, Della Martera, Filippo, Morroni, Gianluca, Mazzanti, Sara, Di Pietrantonio, Maria, Mantini, Paolo, Candelaresi, Bianca, Pallotta, Francesco, Olivieri, Silvia, Iencinella, Valentina, Castelletti, Sefora, Cocci, Emanuele, Polo, Rosaria G., Veccia, Salvatore, Cirioni, Oscar, Tavio, Marcello, Giacometti, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468778/
https://www.ncbi.nlm.nih.gov/pubmed/34572711
http://dx.doi.org/10.3390/antibiotics10091129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468778/
https://www.ncbi.nlm.nih.gov/pubmed/34572711
http://dx.doi.org/10.3390/antibiotics10091129

Ejemplares similares